The days following Ultimate Fighting Championship's (UFC) latest pay-per-view (PPV) endeavor in UFC 183 have been nothing but bad news for Zuffa and fans alike, but preliminary reports suggest UFC 183 did very well at the MGM Grand gate, in PPV buys, and television ratings in the key demographics.
While the focus over the last several days has been on Anderson Silva failing his pre-fight drug screen for performance enhancing drugs (PED) and Nick Diaz failing for marijuana for the third time, UFC brass can at least take a short respite knowing the Las Vegas PPV did exceptionally well in terms of business.
MMAFighting first reported that UFC 183: "Silva vs Diaz" will likely fall between 600,000 and 700,000 PPV buys, falling just short of UFC 182, but earning well above any other PPV since Silva's last fight at UFC 168.
As for FOX Sports 1 (FS1), you can bet they will be delighted with the television ratings for the UFC 183 "Prelims", as nearly two million viewers tuning in for the "Prelims" main event between Miesha Tate and Sara McMann.
According to MMAFighting, "The two-hour average of 1,546,000 viewers for the prelims finished just shy of the FS1 record of 1,554,000 set for the prelims of UFC 168. It would have been the fourth-most watched UFC event since moving to the station."
Of course, these numbers are at least slightly tarnished following both main event competitors testing positive for banned substances. The facts are that while UFC seemingly took a step forward in the month of January with several successful events, the company took a big step back in having the GOAT test positive for drostanolone and androstane.
For more news and information on the Anderson Silva UFC 183 drug testing scandal, follow along on our story stream right here.